Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77:3965–3981. https://doi.org/10.1158/0008-5472.Can-16-2634
Article CAS PubMed PubMed Central Google Scholar
Chan JJ, Tay Y (2018) Noncoding RNA: RNA regulatory networks in cancer. Int J Mol Sci 19(5):1310. https://doi.org/10.3390/ijms19051310
Article CAS PubMed PubMed Central Google Scholar
Chen C, Ding P, Yan W, Wang Z, Lan Y, Yan X, Li T, Han J (2023) Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation. Biochem Pharmacol 214:115643. https://doi.org/10.1016/j.bcp.2023.115643
Article CAS PubMed Google Scholar
Chen W, Wang F, Zhang J, Li C, Hong L (2022) LINC01087 indicates a poor prognosis of glioma patients with preoperative MRI. Funct Integr Genomics 22:55–64. https://doi.org/10.1007/s10142-021-00812-w
Article CAS PubMed Google Scholar
Cheng F, Wang L, Yi S (2022) Long non-coding RNA SNHG1/microRNA-195-5p/Yes-associated protein axis affects the proliferation and metastasis of gastric cancer via the Hippo signaling pathway. Funct Integr Genomics 22:1043–1055. https://doi.org/10.1007/s10142-022-00876-2
Article CAS PubMed Google Scholar
Dong Y, Li J, Han F, Chen H, Zhao X, Qin Q, Shi R, Liu J (2015) High IGF2 expression is associated with poor clinical outcome in human ovarian cancer. Oncol Rep 34:936–942. https://doi.org/10.3892/or.2015.4048
Article CAS PubMed Google Scholar
Feng Y, Yang Y, Fan C, Di S, Hu W, Jiang S, Li T, Ma Z, Chao D, Feng X, Xin Z, Pang S, Li X, Yan X (2016) Pterostilbene inhibits the growth of human esophageal cancer cells by regulating endoplasmic reticulum stress. Cell Physiol Biochem 38:1226–1244. https://doi.org/10.1159/000443071
Article CAS PubMed Google Scholar
Gao W, Gu Y, Li Z, Cai H, Peng Q, Tu M, Kondo Y, Shinjo K, Zhu Y, Zhang J, Sekido Y, Han B, Qian Z, Miao Y (2015) miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Oncogene 34:1629–1640. https://doi.org/10.1038/onc.2014.101
Article CAS PubMed Google Scholar
Georg J, Hess WR (2018) Widespread antisense transcription in prokaryotes. Microbiol Spectr 6. https://doi.org/10.1128/microbiolspec.RWR-0029-2018
Han Q, Li J, Xiong J, Song Z (2020) Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression. J Exp Clin Cancer Res 39:151. https://doi.org/10.1186/s13046-020-01660-5
Article CAS PubMed PubMed Central Google Scholar
Harris LK, Westwood M (2012) Biology and significance of signalling pathways activated by IGF-II. Growth Factors 30:1–12. https://doi.org/10.3109/08977194.2011.640325
Article CAS PubMed Google Scholar
Hu X, Wu J, Xu J (2023) UCA1 executes an oncogenic role in pancreatic cancer by regulating miR-582-5p/BRCC3. Front Oncol 13:1133200. https://doi.org/10.3389/fonc.2023.1133200
Article CAS PubMed PubMed Central Google Scholar
Huang GS, Brouwer-Visser J, Ramirez MJ, Kim CH, Hebert TM, Lin J, Arias-Pulido H, Qualls CR, Prossnitz ER, Goldberg GL, Smith HO, Horwitz SB (2010) Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer. Clin Cancer Res 16:2999–3010. https://doi.org/10.1158/1078-0432.Ccr-09-3233
Article CAS PubMed PubMed Central Google Scholar
Huang H, Li X, Zhang X, Li Z, Han D, Gao W, Liu L, Peng C, Zhu H, Yu X (2022) DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. Acta Biochim Biophys Sin 54:1775–1788. https://doi.org/10.3724/abbs.2022194
Article CAS PubMed PubMed Central Google Scholar
Jin X, Feng J, Cheng X (2022) LncRNA IGF2-AS promotes endometriosis progression through targeting miR-370-3p/IGF2 axis and activating PI3K/AKT/mTOR signaling pathway. J Assist Reprod Genet 39:2699–2710. https://doi.org/10.1007/s10815-022-02638-2
Kopp F, Mendell JT (2018) Functional classification and experimental dissection of long noncoding RNAs. Cell 172:393–407. https://doi.org/10.1016/j.cell.2018.01.011
Article CAS PubMed PubMed Central Google Scholar
Lee EK, Kim HH, Kuwano Y, Abdelmohsen K, Srikantan S, Subaran SS, Gleichmann M, Mughal MR, Martindale JL, Yang X, Worley PF, Mattson MP, Gorospe M (2010) hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat Struct Mol Biol 17:732–739. https://doi.org/10.1038/nsmb.1815
Article CAS PubMed PubMed Central Google Scholar
Li S, Dong R, Kang Z, Li H, Wu X, Li T (2023a) Exosomes: another intercellular lipometabolic communication mediators in digestive system neoplasms? Cytokine Growth Factor Rev 73:93–100. https://doi.org/10.1016/j.cytogfr.2023.06.005
Article CAS PubMed Google Scholar
Li S, Jiang F, Chen F, Deng Y, Huang H (2023b) Silencing long noncoding RNA LINC01133 suppresses pancreatic cancer through regulation of microRNA-1299-dependent IGF2BP3.e23534. https://doi.org/10.1002/jbt.23534
Li T, Yang Z (2018) Melatonin: does it have utility in the treatment of haematological neoplasms? Br J Pharmacol 175:3251–3262. https://doi.org/10.1111/bph.13966
Article CAS PubMed Google Scholar
Li Y, Zhang Z, Yang Y, Ma J (2020) Long Noncoding RNA HOX Transcript antisense RNA gene rs17720428 single nucleotide polymorphism is associated with gastric cancer risk and prognosis. Genet Test Mol Biomark 24:38–46. https://doi.org/10.1089/gtmb.2019.0140
Liu SB, Zhou LB, Wang HF, Li G, Xie QP, Hu B (2020) Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway. Neoplasma 67:129–136. https://doi.org/10.4149/neo_2019_190206N108
Article CAS PubMed Google Scholar
Livingstone C (2013) IGF2 and cancer. Endocr Relat Cancer 20:R321–R339. https://doi.org/10.1530/erc-13-0231
Article CAS PubMed Google Scholar
Ma Z, Fan C, Yang Y, Di S, Hu W, Li T, Zhu Y, Han J, Xin Z, Wu G, Zhao J, Li X, Yan X (2016) Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. Sci Rep 6:35196. https://doi.org/10.1038/srep35196
Article CAS PubMed PubMed Central Google Scholar
Martinez-Quetglas I, Pinyol R, Dauch D, Torrecilla S, Tovar V, Moeini A, Alsinet C, Portela A, Rodriguez-Carunchio L, Solé M, Lujambio A, Villanueva A, Thung S, Esteller M, Zender L, Llovet JM (2016) IGF2 is up-regulated by epigenetic mechanisms in hepatocellular carcinomas and is an actionable oncogene product in experimental models. Gastroenterology 151:1192–1205. https://doi.org/10.1053/j.gastro.2016.09.001
Article CAS PubMed Google Scholar
Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155–159. https://doi.org/10.1038/nrg2521
Article CAS PubMed Google Scholar
Ou JM, Lian WS, Qiu MK, Dai YX, Dong Q, Shen J, Dong P, Wang XF, Liu YB, Quan ZW, Fei ZW (2014) Knockdown of IGF2R suppresses proliferation and induces apoptosis in hemangioma cells in vitro and in vivo. Int J Oncol 45:1241–1249. https://doi.org/10.3892/ijo.2014.2512
Article CAS PubMed Google Scholar
Pastushenko I, Blanpain C (2019) EMT transition states during tumor progression and metastasis. Trends Cell Biol 29:212–226. https://doi.org/10.1016/j.tcb.2018.12.001
Article CAS PubMed Google Scholar
Reymond N, d'Água BB, Ridley AJ (2013) Crossing the endothelial barrier during metastasis. Nat Rev Cancer 13:858–870. https://doi.org/10.1038/nrc3628
Article CAS PubMed Google Scholar
Schagdarsurengin U, Lammert A, Schunk N, Sheridan D, Gattenloehner S, Steger K, Wagenlehner F, Dansranjavin T (2017) Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4. Cell Commun Signal 15:40. https://doi.org/10.1186/s12964-017-0197-7
Article CAS PubMed PubMed Central Google Scholar
Sferruzzi-Perri AN, Sandovici I, Constancia M, Fowden AL (2017) Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth. J Physiol 595:5057–5093. https://doi.org/10.1113/jp273330
Article CAS PubMed PubMed Central Google Scholar
Shen XM, Han S, Liu N, Xu HQ, Yan CX, Yu CJ (2021) LINC00887 aggravates the malignant progression of glioma via upregulating CCND1. Eur Rev Med Pharmacol Sci 25:1928–1935. https://doi.org/10.26355/eurrev_202102_25091
Shi F, Li T, Liu Z, Qu K, Shi C, Li Y, Qin Q, Cheng L, Jin X, Yu T, Di W, Que J, Xia H, She J (2018) FOXO1: another avenue for treating digestive malignancy? Semin Cancer Biol 50:124–131. https://doi.org/10.1016/j.semcancer.2017.09.009
Comments (0)